News Summary

• An expert panel will meet in July to evaluate seven peptides for inclusion on the FDA’s list of substances that can be dispensed by compounding pharmacies.
• The panel will evaluate another five peptides in 2027.
• HHS Secretary Robert F. Kennedy Jr. wants to create a legal pathway for compounding to dispense some peptides that have not passed through the series of studies required for FDA approval.
• Currently, many people purchase their peptides on the gray market, where quality can vary widely.